Example: Heart Attack

Clinical Trials Sponsored by Korean Cancer Study Group

Total 41 results

NCT04761744

Recruiting

A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers

Conditions: DDR Gene Mutation; Metastatic Solid Tumor
NCT04753203

Not yet recruiting

Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients

Conditions: Metastatic Colorectal Cancer; PIK3CA Gene Mutation
NCT04751955

Not yet recruiting

A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

Conditions: Colorectal Cancer Metastatic
NCT03698383

Recruiting

Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer

Conditions: HER2-positive Breast Cancer; Metastatic Breast Cancer
NCT01741116

Completed

Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer

Conditions: Hormone Refractory Prostate Cancer
NCT01224652

Unknown status

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Conditions: Gastric Cancer
NCT00818090

Terminated

Paclitaxel and Cisplatin for Thymic Neoplasm

Conditions: Thymoma; Thymic Carcinoma
NCT00343668

Unknown status

S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

Conditions: Gastric Cancer
NCT04077255

Not yet recruiting

EGFR/FGFR-targeted Therapy for Gastric Cancer

Conditions: Adenocarcinoma of the Stomach
NCT04247633

Recruiting

High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)

Conditions: Breast Cancer
NCT03296306

Recruiting

Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma

Conditions: Bladder Cancer; Ureter Cancer; Urethral Cancer; Transitional Cell Carcinoma
NCT03193788

Unknown status

Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy

Conditions: Bladder Cancer; Ureter Cancer; Transitional Cell Carcinoma
NCT01952951

Unknown status

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer

Conditions: Rectal Neoplasms; Adenocarcinoma
NCT01196559

Completed

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Conditions: Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
NCT00561119

Completed

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Conditions: Advanced Breast Cancer
NCT00287768

Completed

Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

Conditions: Gastric Cancer
NCT03292250

Unknown status

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Conditions: HNSCC; Head and Neck Neoplasms
NCT04202328

Not yet recruiting

T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer

Conditions: Breast Cancer
NCT03423199

Active, not recruiting

PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

Conditions: Breast Neoplasms
NCT03414814

Active, not recruiting

Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation

Conditions: Locally Advanced or Metastatic NSCLC
NCT01536691

Unknown status

Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone

Conditions: Cancer; Malignancy
NCT02114359

Completed

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

Conditions: Gastric Cancer
NCT01593293

Unknown status

Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer

Conditions: Non-small Cell Lung Cancer
NCT00830245

Terminated

A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer

Conditions: Leptomeningeal Carcinomatosis; Non-small Cell Lung Cancer
NCT04061863

Recruiting

Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer